Page last updated: 2024-08-25

sofosbuvir and Acute Kidney Failure

sofosbuvir has been researched along with Acute Kidney Failure in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Abbasy, M; Abdu Allah, AM; Elimam, H; Elnaidany, N; Essa, A; Mohamed Ibraheem, KI; Nada, A; Sabry, A; Shehab-Eldeen, S1
Chander, PN; Chugh, S; Singh, J; Solanki, S; Wolf, DC1
Al Marzooqi, SH; Cerocchi, O; Duarte-Rojo, A; Feld, JJ; Harrell, SM; Janssen, HLA; Karkada, J; Klair, JS; Kowgier, M; Maan, R; Rhodes, KD1
Dashti-Khavidaki, S; Khalili, H; Nasiri-Toosi, M1
Easley, KA; Kalapila, AG; Kyle, AW; Michal, JL; Miller, LS; Patel, M; Rab, S1
Jhaveri, KD; Schwartz, D; Thakkar, J; Wanchoo, R1
Chen, YS; Kao, JH; Liu, CH; Wang, SS1

Reviews

1 review(s) available for sofosbuvir and Acute Kidney Failure

ArticleYear
Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors.
    Expert review of clinical pharmacology, 2018, Volume: 11, Issue:5

    Topics: Acute Kidney Injury; Antiviral Agents; Drug Monitoring; Hepatitis C; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Risk Factors; Sofosbuvir; Time Factors

2018

Other Studies

6 other study(ies) available for sofosbuvir and Acute Kidney Failure

ArticleYear
Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir.
    Canadian journal of gastroenterology & hepatology, 2020, Volume: 2020

    Topics: Acute Kidney Injury; Adult; Antiviral Agents; Carbamates; Drug Therapy, Combination; Egypt; Female; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney; Lipocalin-2; Male; Middle Aged; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Valine

2020
Acute Renal Failure in a Patient on Ledipasvir-Sofosbuvir Therapy for Hepatitis C.
    American journal of therapeutics, 2020, 07-31, Volume: 28, Issue:6

    Topics: Acute Kidney Injury; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Sofosbuvir; Treatment Outcome

2020
The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir-based regimens.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oligopeptides; Proline; Risk Factors; Sofosbuvir

2017
Incidence of Acute Kidney Injury in Patients Coinfected with HIV and Hepatitis C Virus Receiving Tenofovir Disoproxil Fumarate and Ledipasvir/Sofosbuvir in a Real-World, Urban, Ryan White Clinic.
    AIDS research and human retroviruses, 2018, Volume: 34, Issue:8

    Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Female; Fluorenes; Georgia; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Sofosbuvir; Tenofovir; Young Adult

2018
Harvoni (Ledipasvir With Sofosbuvir)-Induced Renal Injury.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:1

    Topics: Acute Kidney Injury; Antiviral Agents; Benzimidazoles; Female; Fluorenes; Humans; Middle Aged; Sofosbuvir; Uridine Monophosphate

2016
Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:5

    Topics: Acute Kidney Injury; Antiviral Agents; Benzimidazoles; Fluorenes; Heart Failure; Heart Transplantation; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Function Tests; Male; Middle Aged; Myocardial Infarction; Sofosbuvir; Treatment Outcome; Uridine Monophosphate

2017